Michael Schaffzin | IR, Stern Investor Relations |
Derek Chalmers | President & Chief Executive Officer |
Mani Mohindru | Chief Financial Officer and Chief Strategy Officer |
Joe Stauffer | Chief Medical Officer |
Charles Duncan | Piper Jaffray |
Annabel Samimy | Stifel |
Alan Carr | Needham & Company |
Arlinda Lee | Canaccord |
Michael Jung | Seaport Global Securities |
Good afternoon and welcome to Cara Therapeutics' fourth quarter and full-year 2017 financial results conference call. All participants are now in listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Cara's request. I would now like to turn the call over to the Cara team.